NCT01629875View on ClinicalTrials.gov

Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

PHASE3CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions
Moderate to Severe Glabellar Line
Interventions
DRUG

Generic equivalent of Clostridium Botulinum A Toxin

DRUG

Botox (Clostridium Botulinum A Toxin)

Trial Locations (1)

Unknown

Chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY